文献速递妇科

妇科癌症远程医疗使用差异:差距扩大还是缩小?

Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?
PubMed 文献 · Gynecol Oncol · 2024-02-05

该回顾性队列研究基于美国电子健康记录数据库(约800个站点,学术机构占14%、社区机构占86%),纳入2020年3月至2021年10月至少就诊一次的子宫内膜癌和上皮性卵巢癌患者,分析远程医疗使用与种族、保险、地区等因素的关联。结果显示卵巢癌患者中28.3%、子宫内膜癌患者中28.7%至少使用过一次远程医疗;社区肿瘤实践中黑人患者较白人患者使用远程医疗的可能性更低(卵巢癌RR 0.62,95%CI 0.42-0.9;子宫内膜癌RR 0.56,95%CI 0.38-0.83),且存在地区、保险类型差异。

要点

  • 卵巢癌和子宫内膜癌患者中分别有28.3%和28.7%至少使用过一次远程医疗。
  • 社区实践中黑人患者较白人患者使用远程医疗的可能性更低(卵巢癌RR 0.62;子宫内膜癌RR 0.56)。
  • 美国东南部、中西部、西部和波多黎各患者较东北部患者使用远程医疗的可能性更低。

核心结论

  • 在这项全国性队列研究中,不足30%的患者曾使用远程医疗,使用率存在显著的种族和地区差异。
  • 远程医疗扩展工作应包括改善远程医疗可及性公平性的项目。

研究设计与样本

  • 回顾性队列研究,使用真实世界电子健康记录衍生数据库,代表美国约800个站点,其中学术机构占14%、社区机构占86%。
  • 纳入2020年3月至2021年10月至少就诊一次的子宫内膜癌和上皮性卵巢癌患者。
  • 采用多变量泊松回归分析曾使用远程医疗与患者、社会人口学、卫生系统和癌症因素之间的关联。

主要发现

  • 3950例卵巢癌患者中1119例(28.3%)至少有一次远程医疗就诊。
  • 2510例子宫内膜癌患者中720例(28.7%)至少有一次远程医疗就诊。
  • 在社区肿瘤实践中,黑人患者较白人患者使用远程医疗的可能性更低(卵巢癌:RR 0.62,95%CI 0.42-0.9;子宫内膜癌:RR 0.56,95%CI 0.38-0.83)。
  • 美国东南部、中西部、西部和波多黎各患者较东北部患者使用远程医疗的可能性更低。
  • 无保险患者较有私人保险者使用远程医疗的可能性更低,而医疗保险(Medicare)患者较有私人保险者使用远程医疗的可能性更高。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Telemedicine rapidly increased with the COVID-19 pandemic and could reduce cancer care disparities. Our objective was to evaluate sociodemographic (race, insurance), patient, health system, and cancer factors associated with telemedicine use in gynecologic cancers. METHODS: We conducted a retrospective cohort study of patients with endometrial cancer and epithelial ovarian cancer with at least one visit from March 2020 to October 2021, using a real-world electronic health record-derived database, representing approximately 800 sites in US academic (14%) and community practices (86%). We used multivariable Poisson regression modeling to analyze the association of ever using telemedicine with patient, sociodemographic, health system, and cancer factors. RESULTS: Of 3950 patients with ovarian cancer, 1119 (28.3%) had at least one telemedicine visit. Of 2510 patients with endometrial cancer, 720 (28.7%) had at least one telemedicine visit. At community cancer practices, patients who identified as Black were less likely to have a telemedicine visit than patients who identified as white in both ovarian and endometrial cancer (Ovarian: RR 0.62, 95% CI 0.42-0.9; Endometrial: RR 0.56, 95% CI 0.38-0.83). Patients in the Southeast, Midwest, West, and Puerto Rico were less likely to have telemedicine visits than patients in the Northeast. Uninsured patients were less likely, and patients with Medicare were more likely, to have one or more telemedicine visit than patients with private insurance. CONCLUSIONS: In this national cohort study, <30% of patients ever used telemedicine, and significant racial and regional disparities existed in utilization. Telemedicine expansion efforts should include programs to improve equity in access to telemedicine.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Smith AJB, Gleason EG, Andriani L, et al. Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities? Gynecol Oncol. 2024. PMID: 38320467. doi:10.1016/j.ygyno.2024.01.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。